Theravance Biopharma (TBPH) Misses Q1 EPS by 33c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. BA
4. STX
5. NXPI
6. KIDS
7. V
8. CSGP
9. UPS
10. MANH

Go back to Theravance Biopharma (TBPH) Misses Q1 EPS by 33c, Revenues Beat

Theravance Biopharma, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

May 6, 2020 4:06 PM EDT

DUBLIN, May 6, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the first quarter ended March 31, 2020. Revenue for the first quarter 2020 was $19.9 million. Operating loss was $72.5 million, or $57.2 million excluding share-based compensation expense. Cash, cash equivalents and marketable securities totaled $492.1 million as of March 31, 2020.

... More